Teladoc Health (NYSE:TDOC) Releases FY24 Earnings Guidance

Teladoc Health (NYSE:TDOC) issued an update on its FY24 earnings guidance on Thursday morning. The company provided EPS guidance of ($1.10)-($0.80) for the period, compared to the consensus EPS estimate of ($1.03). The company issued revenue guidance of $2.635-$2.735 billion, compared to the consensus revenue estimate of $2.66 billion. Teladoc Health also updated its Q2 guidance to ($0.45)-($0.35) EPS.

Teladoc Health Stock Down 2.9 %

Shares of Teladoc Health stock traded down $0.40 during trading on Thursday, reaching $13.33. 6,550,543 shares of the company traded hands, compared to its average volume of 4,757,382. The firm has a market capitalization of $2.26 billion, a PE ratio of -9.95 and a beta of 0.94. The company has a 50 day moving average price of $15.31 and a 200-day moving average price of $17.83. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.54 and a quick ratio of 3.47. Teladoc Health has a 1-year low of $12.85 and a 1-year high of $30.41.

Teladoc Health (NYSE:TDOC) last posted its earnings results on Tuesday, February 20th. The health services provider reported ($0.17) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.22) by $0.05. The firm had revenue of $660.50 million during the quarter, compared to analyst estimates of $670.79 million. Teladoc Health had a negative net margin of 8.47% and a negative return on equity of 9.22%. The business’s revenue was up 3.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.23) EPS. As a group, equities research analysts expect that Teladoc Health will post -1.07 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

TDOC has been the topic of several recent research reports. SVB Leerink initiated coverage on shares of Teladoc Health in a report on Monday, February 26th. They set a market perform rating and a $17.00 price objective on the stock. Piper Sandler lowered their price target on shares of Teladoc Health from $30.00 to $25.00 and set an overweight rating on the stock in a report on Wednesday, February 21st. Needham & Company LLC reissued a hold rating on shares of Teladoc Health in a report on Friday, April 5th. Cantor Fitzgerald initiated coverage on shares of Teladoc Health in a report on Thursday, February 29th. They issued an overweight rating and a $22.00 price target on the stock. Finally, DA Davidson lowered their price target on shares of Teladoc Health from $22.00 to $18.00 and set a neutral rating on the stock in a report on Wednesday, February 21st. Eight investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of Hold and a consensus target price of $22.23.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, CAO Richard J. Napolitano sold 3,765 shares of the firm’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $54,667.80. Following the completion of the transaction, the chief accounting officer now owns 18,077 shares of the company’s stock, valued at $262,478.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other news, EVP Andrew Turitz sold 6,190 shares of Teladoc Health stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total value of $89,878.80. Following the completion of the transaction, the executive vice president now owns 39,429 shares of the company’s stock, valued at approximately $572,509.08. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CAO Richard J. Napolitano sold 3,765 shares of Teladoc Health stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total value of $54,667.80. Following the completion of the transaction, the chief accounting officer now directly owns 18,077 shares of the company’s stock, valued at approximately $262,478.04. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 135,441 shares of company stock valued at $2,038,251. 1.63% of the stock is currently owned by company insiders.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.